Author/Authors :
Karagün, Ebru Department of Dermatology - Ağrı State Hospital, Ağrı, Turkey , Ergin, Can Department of Dermatology - Dışkapı Yıldırım Beyazıt Education and Research Hospital, Ankara, Turkey , Baysak, Sevim Department of Dermatology - Bandırma State Hospital, Balikesir, Turkey , Erden, Gönül Department of Medical Biochemistry - Faculty of Medicine - Hacettepe University, Ankara, Turkey , Aktaş, Habibullah Department of Dermatology - Education and Research Hospital - Karabük University, Karabük, Turkey , Ekiz, Özlem Department of Dermatology - Faculty of Medicine - Mustafa Kemal University, Hatay, Turkey
Abstract :
Introduction
Vitiligo is a common acquired pigmentary skin disorder. Vitamin D is responsible for skin pigmentation, increases tyrosinase activity and melanogenesis, and exhibits immunoregulatory functions. Low levels of vitamin D are associated with many autoimmune diseases, including systemic lupus, diabetes mellitus, rheumatoid arthritis, multiple sclerosis and alopecia areata. Few reports have evaluated serum vitamin D levels in vitiligo patients, and their results are conflicting.
Aim
To evaluate serum vitamin D levels of vitiligo patients and compare the results with controls.
Material and methods
In total, 50 vitiligo patients and 47 controls were enrolled in the study. Vitamin D levels were measured from blood samples. Group comparisons were performed using appropriate statistical methods.
Results
The patients had lower serum vitamin D levels than the controls, but this difference was not significant (p = 0.570).
Conclusions
It remains unknown whether vitamin D deficiency causes vitiligo. Larger controlled studies are required to prove whether low circulating vitamin D is a causative factor in vitiligo.
Keywords :
vitiligo , vitamin D , autoimmune diseases , etiopathogenesis